Why ESR1 Mutation Monitoring Can Keep One Step Ahead of Breast Cancer
For patients with metastatic HR+ breast cancer, there may be no test more important than monitoring for an ESR1 mutation.
Read MorePosted by Chris Wolski | Feb 26, 2024 | Breast |
For patients with metastatic HR+ breast cancer, there may be no test more important than monitoring for an ESR1 mutation.
Read MorePosted by Chris Wolski | Feb 26, 2024 | Company News |
California-based Mountain View Medical Laboratory has announced a complete rebranding of its business to become “Gnosis.”
Read MorePosted by Chris Wolski | Feb 26, 2024 | Cancer |
The team will work to improve the genetic testing and clinical management of hereditary and multiple primary cancers in African Americans.
Read MorePosted by Andy Lundin | Feb 22, 2024 | Diagnostic Technologies |
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis.
Read MorePosted by Andy Lundin | Feb 15, 2024 | Diagnostic Technologies |
PrecisionLife and Metrodora Institute will support the diagnosis for a range of complex, chronic diseases including Long COVID.
Read More